About Advanov Pharma
Science-led. Quality-driven. Patient-focused.
Founded in 2017 by Hemal Shah, Advanov Pharma is driven by Advance and Novel—delivering innovative, differentiated healthcare products, accelerating global market access, and making quality medicines accessible through excellence, agility, and trusted partnerships.
Mr. Hemal Shah
Founder & Managing Director
20+ Years of Global Pharmaceutical Leadership
A visionary entrepreneur with over two decades of international experience in sales, marketing, business development and global commercialization.
Our Inspiration
Advanov is inspired by the words "Advance" and "Novel" – reflecting our commitment to advancing healthcare through innovative solutions, strategic thinking and novel approaches to global pharmaceutical growth.
His Journey
Mr. Hemal Shah began his pharmaceutical journey in 1999 after completing his MBA. He has held key leadership roles across domestic and international markets with leading organizations including Zydus Cadila, GlaxoSmithKline (GSK), AstraZeneca, Johnson & Johnson, Claris, and Nirma (Aculife).
The Advanov Journey:
Advancing in a
Novel Way
From a vision in 2016 to a global pharmaceutical partner today – our journey is built on trust, innovation, and unwavering commitment.
Driven by Innovation
Pioneering solutions for a healthier tomorrow.
Global Vision
Expanding our footprint, impacting lives worldwide.
Trusted Quality
Committed to excellence in every product.
Stronger Partnerships
Building lasting relationships for sustainable growth.
Future Ready
Continuously evolving to create greater value.
Under his leadership, Advanov Pharma has rapidly evolved into a globally expanding pharmaceutical company registering robust and exponential growth in:
Exports Revenue
Growing in 35+ markets
Intellectual Property
Patents & proprietary dossiers
Country-based Operations
Local entities across regions
Strategic Partnerships
With global & regional leaders
International Market Access
EU, LATAM, SEA & beyond
An Integrated
Pharmaceutical
Platform
At the intersection of science, regulation and global market access.
Advanov Pharma Private Limited is a fully integrated pharmaceutical company with end-to-end ownership across the product lifecycle, transforming selected molecules into commercially viable, regulatory-compliant and globally scalable pharmaceutical assets.
Our Integrated Operating Model
Product Selection
Science-led evaluation and market opportunity assessment
Regulatory Structuring
Pathway design, dossier strategy and compliance planning
Manufacturing Alignment
GMP partners, tech-transfer and quality assurance alignment
Market Access
Regional filings, approvals and lifecycle management
Commercial Expansion
Go-to-market execution, brand building and sustainable growth
Our Philosophy
Advanced
Represents our commitment to scientific depth, complex capabilities and global quality standards.
Novel
Represents our focus on original strategies, new opportunities and creating differentiated value.
Our Vision
To be a globally trusted pharmaceutical company recognized for advanced products, novel strategies and sustainable global growth.
Our Mission
To develop high-value pharmaceuticals and enable better access to essential medicines through global collaboration and responsible innovation.
Strategic Outcome
Science
Advanced research and development for complex and differentiated products
Regulation
Global compliance and regulatory excellence for faster market access
Commercialization
Market expansion and patient impact through strategic partnerships
Science enables advancement. Strategy enables expansion.
This is the Advanov way.
Driven by science, strategy and execution excellence, we build meaningful pharmaceutical partnerships that improve healthcare access and create long-term value across international markets.